Home - Products - Others - Other Targets - Cap-dependent endonuclease-IN-1

Cap-dependent endonuclease-IN-1

CAS No. 2365473-17-0

Cap-dependent endonuclease-IN-1( —— )

Catalog No. M35745 CAS No. 2365473-17-0

Cap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 967 Get Quote
5MG 1292 Get Quote
25MG 2052 Get Quote
50MG 2558 Get Quote
100MG 3168 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cap-dependent endonuclease-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Cap-dependent endonuclease-IN-1 is a highly potent, orally active cap-dependent endonuclease inhibitor with antiviral activity for studying influenza virus infection.
  • Description
    Cap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2365473-17-0
  • Formula Weight
    540.54
  • Molecular Formula
    C27H22F2N2O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2(CN(N3C1=C(OCOC(OC)=O)C(=O)C=C3)[C@H]4C=5C(CSC=6C4=CC=CC6)=C(F)C(F)=CC5)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. Patent WO2019144089A1.
molnova catalog
related products
  • 2-Methoxy-5-sulfamoy...

    Used as intermediates in organic synthesis sulpiride.

  • CINPA1

    CINPA1 is a selective inhibitor of constitutive androstane receptor (CAR) with an IC50 of 70 nM for CAR-mediated transcription. CINPA1 can be used in studies about CAR function.

  • ST 271

    ST271 is an effective protein tyrosine kinase (PTK) inhibitor.